UPDATE | August 23, 2024

How can (bio)pharmaceutical companies contribute to improving global access to essential medications?

  • MAIL

How can (bio)pharmaceutical companies contribute to improving global access to essential medications?


In today's rapidly evolving biopharmaceutical landscape, the collaboration between innovative biopharmaceutical companies and resource-rich CDMOs is vital for ensuring global access to essential medications. In this roundtable discussion, Justin Kong, Associate Director of Project Management, explores how these strategic partnerships are accelerating the delivery of life-saving treatments to patients worldwide.


Read more

How can (bio)pharmaceutical companies contribute to improving global access to essential medications?


In today's rapidly evolving biopharmaceutical landscape, the collaboration between innovative biopharmaceutical companies and resource-rich CDMOs is vital for ensuring global access to essential medications. In this roundtable discussion, Justin Kong, Associate Director of Project Management, explores how these strategic partnerships are accelerating the delivery of life-saving treatments to patients worldwide.


Read more

  • CDO
  • CGMP
  • ADC
  • Bio Campus
  • IR
  • CMO

Share article

  • MAIL

SITE MAP

close
Close

Your download is ready

Click Download.

Close

Subscribe to Our Newsletter

Please fill in your details, select one or more areas of interest, and click the subscribe button to receive our newsletter.

Subscribe to Our Newsletter
  • Interests
  • Privacy Policy to collect the email address that I have provided until I withdraw my consent. The collected information will only be used for the purpose of mailing service. If you do not wish to consent, you will not be able to receive the newsletter. Samsung Biologics respects the privacy of its subscribers.
Close

Please fill out the form
to view the full content

Please sign up to view the post..
* Required
Privacy Policy required